The eIF5A hypusination inhibitor GC7 improves tolerance of pancreatic beta cells to ischemia/reperfusion
American Journal of Physiology-Cell Physiology · 01.01.2026 · 330 (1) · C56-C69
DOI: 10.1152/ajpcell.00631.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.01.2026. Verfasst von Hajar Ouahmi und 8 weiteren Autor:innen. Beteiligte Einrichtung: LP2M, Université Côte d'Azur, CNRS, France. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Reperfusion Injury, Peptide Initiation Factors, RNA-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Fondation pour la Recherche Médicale (FRM), Société Francophone du Diabète (SFD).
Abstract (Originalsprache)
Treatment of rodent beta cell line with GC7, an inhibitor of eIF5A hypusination, reversibly slows down mitochondrial activity and shifts the cells’ energy metabolism toward anaerobic glycolysis. As a result, GC7 treatment transiently inhibits ATP production and insulin secretion in response to glucose. These changes enhance the resistance of pancreatic beta cell line to ischemia/reperfusion by reducing oxidative stress and improving cell survival, highlighting the potential anti-ischemic benefits of GC7 for pancreatic islet transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LP2M, Université Côte d'Azur, CNRS, France.
- Service de Néphrologie Dialyse et Transplantation, Hôpital Pasteur 2, CHU Nice, Nice, France.
ORCID-Profile: Filippo Massa, Isabelle Rubera, Didier F Pisani
Förderung
- Fondation pour la Recherche Médicale (FRM)
- Société Francophone du Diabète (SFD)
Zitieren
APA
Ouahmi, H., Massa, F., Cougnon, M., Rubera, I., Jarretou, G., Tauc, M., Van Obberghen, E., Sicard, A., & Pisani, D. F. (2026). The eIF5A hypusination inhibitor GC7 improves tolerance of pancreatic beta cells to ischemia/reperfusion. American Journal of Physiology-Cell Physiology, 330(1), C56-C69. https://doi.org/10.1152/ajpcell.00631.2025
Vancouver
Ouahmi H, Massa F, Cougnon M, Rubera I, Jarretou G, Tauc M, et al. The eIF5A hypusination inhibitor GC7 improves tolerance of pancreatic beta cells to ischemia/reperfusion. American Journal of Physiology-Cell Physiology. 2026;330(1):C56-C69. doi:10.1152/ajpcell.00631.2025
BibTeX
@article{Ouahmi2026,
author = {Ouahmi, Hajar and Massa, Filippo and Cougnon, Marc and Rubera, Isabelle and Jarretou, Gisèle and Tauc, Michel and Van Obberghen, Emmanuel and Sicard, Antoine and Pisani, Didier F},
title = {The eIF5A hypusination inhibitor GC7 improves tolerance of pancreatic beta cells to ischemia/reperfusion},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
volume = {330},
number = {1},
pages = {C56--C69},
doi = {10.1152/ajpcell.00631.2025}
}
EUVIMED